NDC11 63323049441
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 63323-0494-41 | 63323-0494 |
| 63323-494-41 | 63323-494 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Valproate Sodium | VALPROATE SODIUM | Fresenius Kabi USA, LLC | 3dfb6da1-f66a-4618-9f74-d2d6c16c0b58 | 2024-12-15 | Boxed warning, Warnings, Adverse reactions | 63323-494-41 63323-494 63323049441 |
| Valproate Sodium | VALPROATE SODIUM | Fresenius Kabi USA, LLC | c572ece7-03d3-4c2a-aeb5-61f2023b28ea | 2024-10-24 | Boxed warning, Warnings, Adverse reactions | 63323-494 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.